Roche trumpets potential ‘best-in-class’ obesity drug
Roche has reported early clinical data with its candidate obesity …
Newsletters and Deep Dive digital magazine
Roche has reported early clinical data with its candidate obesity …
This week, pharmaphorum heads to the Big Apple for the FT US Pharma …
Bristol-Myers Squibb has chalked up another FDA approval for its …
GSK has become the first founding partner of the new Fleming …
Legislation that would restrict US organisations from contracting …
New start-up Uniquity Bio arrived on the scene today with $300 …
Your Roadmap for mRNA Process Development & Manufacturing with …
Five home-testing devices for obstructive sleep apnoea hypopnoea …
Eisai and Biogen have filed a rolling biologics license application …
AbbVie has agreed to pay $65 million on an option deal with start-up …
The US FDA has approved a human papillomavirus (HPV) self-sampling …
The FDA is asking digital health technology developers to come up with a solution to measuring a common symptom of Parkinson’s disease that can have a serious impact on pa
The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to t
Patients, healthcare professionals, payers, and other stakeholders can have vastly different views on the value of a particular product, often resulting in a struggle between prioritising a
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though